Get started
Author

Yolanda Lage

Negative association of steroids with immunotherapy efficacy in a multi-tumor cohort: time and dose-dependent
2024 · Víctor Albarrán, Patricia Guerrero, et al. · Cancer Immunology Immunotherapy · 35
PDF
Targeting KRAS in Non-Small Cell Lung Cancer
2022 · Elena Corral de la Fuente, Maria Eugenia Olmedo Garcia, et al. · Frontiers in Oncology · 35
PDF
Limited T cell response to SARS-CoV-2 mRNA vaccine among patients with cancer receiving different cancer treatments
2022 · Alfonso Cortés, José L. Casado, et al. · European Journal of Cancer · 28
PDF
Immune checkpoint inhibitors-associated thrombosis in patients with lung cancer and melanoma: a study of the Spanish society of medical oncology (SEOM) thrombosis and cancer group
2022 · Manuel Sánchez Cánovas, David Fernández Garay, et al. · Clinical & Translational Oncology · 27
New horizons for uncommon mutations in non-small cell lung cancer: BRAF, KRAS, RET, MET, NTRK, HER2
2022 · Maria Eugenia Olmedo, Raquel Cervera, et al. · World Journal of Clinical Oncology · 19
Blood Biomarkers of Response to Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
2022 · Yolanda Lage Alfranca, María Eugenia Olmedo Garcia, et al. · Journal of Clinical Medicine · 15
PDF
Sarcoidosis-like reactions in cancer patients treated with immune checkpoint inhibitors: experience in a Spanish hospital
2021 · J. Torres-Jiménez, J. Esteban-Villarrubia, et al. · Clinical & Translational Oncology · 13
Anti-Zic4 paraneoplastic cerebellar degeneration in a patient with EGFR-mutated NSCLC: a case report
2022 · Javier Pozas, Víctor Albarrán-Fernández, et al. · Translational Lung Cancer Research · 11
PDF
Acute anti-Ma2 paraneoplastic encephalitis associated to pembrolizumab: a case report and review of literature
2021 · Víctor Albarrán, Javier Pozas, et al. · Translational Lung Cancer Research · 11
PDF
Detrimental effect of an early exposure to antibiotics on the outcomes of immunotherapy in a multi-tumor cohort of patients
2024 · Patricia Guerrero, Víctor Albarrán, et al. · The Oncologist · 10
PDF
Actionable Genomic Alterations in Large Cell Neuroendocrine Carcinoma: A European Case Series of Patients Treated With a Small Molecule Inhibitor
2025 · Frank W.J. Heijboer, Marta Brambilla, et al. · JCO Precision Oncology · 6
Challenges in Management of Patients With Lung Cancer in Times of COVID-19: An Imaging Perspective
2020 · Luis Gorospe, Ana María Ayala-Carbonero, et al. · Clinical Lung Cancer · 4
PDF
Dermatofibrosarcoma Protu-Berans with Lung Metastasis Requiring Pneumonectomy
2015 · Ana Collazo Lorduy, Berta Obispo, et al. · Rare Tumors · 4
Brief report: High incidence of peridiagnosis thromboembolic events in patients with BRAF-mutant lung cancer
2023 · Inmaculada Aparicio, Patricia Iranzo, et al. · Thrombosis Research · 3
PDF
Carcinoma microcítico de pulmón
2025 · J. Chamorro, M.E. Olmedo, et al. · Medicine - Programa de Formación Médica Continuada Acreditado · 2
ALK rearranged non–small cell lung carcinoma with EML4-NTRK3 fusion as a possible mechanism of resistance to third-generation ALK inhibitors
2021 · Elena Corral de la Fuente, Amparo Benito Berlinches, et al. · Current Problems in Cancer Case Reports · 2
PDF
Differentiation of bland versus tumor thrombus in a lung cancer patient with an implanted central venous access device and a superior vena cava syndrome: 18F-FDG PET/CT findings
2021 · Luis Gorospe, Odile Ajuria-Illarramendi, et al. · Japanese Journal of Clinical Oncology · 2
Real-World Data of First-Line Cemiplimab Monotherapy for Metastatic Non-Small Cell Lung Cancer (NSCLC) with PD-L1 Expression ≥ 50%: A National Spanish Multicentric Cohort (CEMI-SPA Study)
2025 · Silvia Masini, Monica Antoñanzas Basa, et al. · Cancers · 1
PDF
Carcinoma de pulmón de célula no pequeña
2025 · Y. Lage, M. García-Pardo, et al. · Medicine - Programa de Formación Médica Continuada Acreditado · 1
Characterization of thrombosis risk in ambulatory patients with cancer: results of the observational, prospective, multicenter CARTAGO study
2024 · Javier Trujillo-Santos, Ignacio García-Escobar, et al. · The Oncologist · 1
Response to Mobocertinib in a patient with advanced Non-Small Cell Lung Cancer harboring EGFR exon 20 insertion after several therapies including Amivantamab
2022 · Elena Corral de la Fuente, María Eugenia Olmedo García, et al. · Current Problems in Cancer Case Reports · 1
PDF
6P Clinical and molecular characteristics in non-small cell lung cancer patients with alteration in PIK3 pathway
2021 · Y. Lage, P. Álvarez Ballesteros, et al. · Journal of Thoracic Oncology · 1
COVID-19: Thoracic Diagnostic Interventional Procedures in Troubled Times
2020 · Luis Gorospe, Ana María Ayala-Carbonero, et al. · Archivos de Bronconeumología · 1
COVID-19: intervencionismo diagnóstico torácico en tiempos difíciles
2020 · Luis Gorospe, Ana María Ayala-Carbonero, et al. · Archivos de Bronconeumología · 1
PDF
Posterior Reversible Encephalopathy Syndrome (PRES) in a Patient Treated with a Novel Combination Treatment with Anti PDL1 Antibody (Durvalumab) and VEGFR2 Antibody (Ramucirumab)
2019 · Jaime Rubio Perez, Roberto Hernández, et al. · Archives of Clinical and Medical Case Reports · 1
Works count: 52
Citation count: 232
H-index: 10
I10-index: 10
Year
Topic
Type